Institutions / Sphera Funds Management Ltd.
Sphera Funds Management Ltd.
CIK 1496201 · Institution · as of Dec 31, 2025
Portfolio value
$478.53M
Positions
94
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 94 →
| Company | Value | % of portfolio |
|---|---|---|
| Teva Pharmaceutical Industries LtdTEVA | $35.07M | 7.3% |
| Biogen Inc. | $16.67M | 3.5% |
| Mineralys Therapeutics IncMLYS | $16.29M | 3.4% |
| Syndax Pharmaceuticals Inc | $16.02M | 3.3% |
| Nova Ltd | $15.71M | 3.3% |
| Tower Semiconductor Ltd | $14.39M | 3.0% |
| Cogent Biosciences, Inc. | $13.44M | 2.8% |
| Astrazeneca PLC | $12.42M | 2.6% |
| Sanofi | $11.61M | 2.4% |
| ELI LILLY & Co | $9.72M | 2.0% |
| Amicus Therapeutics Inc | $9.38M | 2.0% |
| Immatics N.V | $9.04M | 1.9% |
| BioMarin Pharmaceutical Inc | $8.74M | 1.8% |
| BridgeBio Pharma, Inc. | $8.24M | 1.7% |
| Oric Pharmaceuticals, Inc. | $8.22M | 1.7% |
| Dyne Therapeutics, Inc. | $7.69M | 1.6% |
| Trevi Therapeutics, Inc. | $7.49M | 1.6% |
| Johnson & Johnson | $7.42M | 1.5% |
| Savara IncSVRA | $7.10M | 1.5% |
| Scholar Rock Holding Corp | $6.97M | 1.5% |
| Wave Life Sciences Ltd | $6.94M | 1.5% |
| Ultragenyx Pharmaceutical Inc. | $6.91M | 1.4% |
| Cybin Inc. | $6.75M | 1.4% |
| Annexon, Inc. | $6.61M | 1.4% |
| Biocryst Pharmaceuticals Inc | $6.54M | 1.4% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.